Published in Arterioscler Thromb Vasc Biol on August 01, 2001
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial. J Infect Dis (2011) 2.10
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol (2005) 1.49
Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One (2010) 1.30
Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob Agents Chemother (2007) 1.15
Preadmission statin use and one-year mortality among patients in intensive care - a cohort study. Crit Care (2010) 1.07
Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med (2008) 1.05
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol (2011) 1.02
Statins for community-acquired pneumonia: current state of the science. Eur J Clin Microbiol Infect Dis (2009) 0.99
Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice. Antimicrob Agents Chemother (2005) 0.96
MicroRNA-152 mediates DNMT1-regulated DNA methylation in the estrogen receptor α gene. PLoS One (2012) 0.93
Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol (2010) 0.92
Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome. J Neurol Sci (2010) 0.91
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease. Br J Pharmacol (2008) 0.89
Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arterioscler Thromb Vasc Biol (2001) 0.89
HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection. BMC Cardiovasc Disord (2003) 0.82
Statins as modulators of regulatory T-cell biology. Mediators Inflamm (2013) 0.81
Is serum cholesterol a risk factor for asthma? Lung India (2013) 0.78
The many roles of statins in ischemic stroke. Curr Neuropharmacol (2014) 0.77
Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage. J Neuroinflammation (2007) 0.76
Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target? Intensive Care Med Exp (2014) 0.75
Evidence for simvastatin anti-inflammatory actions based on quantitative analyses of NETosis and other inflammation/oxidation markers. Results Immunol (2014) 0.75
The association of prior statin use in septic shock treated with early goal directed therapy. Eur J Emerg Med (2012) 0.75
Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD? J Clin Med (2016) 0.75
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol (1998) 5.32
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity (1997) 4.19
Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest (1983) 3.47
Neurotoxicity of a prion protein fragment. Nature (1993) 3.38
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet (1978) 3.15
CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid. Nature (1999) 2.81
Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis. Eur J Clin Nutr (2012) 2.72
Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. J Thromb Haemost (2005) 2.18
Synapsis and the formation of paranemic joints by E. coli RecA protein. Cell (1983) 2.14
Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med (1988) 2.10
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
Ambulatory blood pressure: normality and comparison with other measurements. Hypertension Working Group. Hypertension (1999) 2.01
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem (1997) 1.97
Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest (1982) 1.90
Regulation of the macrophage content of neoplasms by chemoattractants. Science (1983) 1.83
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J Exp Med (1997) 1.70
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
Bladder carcinoma in Costello syndrome: report on a patient born to consanguineous parents and review. Am J Med Genet (1999) 1.67
The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr Drug Targets (2000) 1.61
Evaluation of quinacrine treatment for prion diseases. J Virol (2003) 1.59
A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurol Scand (1990) 1.51
Evidence that vascular endothelial cells can induce the retraction of fibrin clots. Proc Soc Exp Biol Med (1981) 1.51
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. Ann Oncol (2013) 1.49
Effect of nifedipine on morphine-induced analgesia. Anesth Analg (1990) 1.46
Organic coronary stenosis in Prinzmetal's variant angina. J Cardiol (1997) 1.46
The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg (2000) 1.43
Prostacyclin and human foetal circulation. Prostaglandins (1979) 1.42
Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci U S A (1998) 1.42
Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients. J Thromb Haemost (2003) 1.42
Cancer cell procoagulant activity: evaluation by an amidolytic assay. Thromb Res (1980) 1.41
Molecular cloning and functional characterization of brefeldin A-ADP-ribosylated substrate. A novel protein involved in the maintenance of the Golgi structure. J Biol Chem (1999) 1.39
Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest (2000) 1.38
Vertebral and carotid artery dissection following chiropractic cervical manipulation. Neurosurg Rev (1999) 1.38
Large tunable Rashba spin splitting of a two-dimensional electron gas in Bi2Se3. Phys Rev Lett (2011) 1.37
Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood (1996) 1.37
Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine (1991) 1.37
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem (2000) 1.34
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33
Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase. Regulation of its transcript by interferons in vivo. Biochem J (1992) 1.30
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport (1993) 1.28
Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene (2007) 1.28
Structure and expression of a gene from Arabidopsis thaliana encoding a protein related to SNF1 protein kinase. Gene (1992) 1.26
Identification of the yeast DNA polymerase I gene with antibody probes. Curr Genet (1985) 1.25
Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun (1993) 1.23
Relationship of Beck Depression Inventory factors to depression among adolescents. J Affect Disord (1997) 1.22
CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci U S A (1996) 1.22
Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett (2001) 1.21
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res (1997) 1.21
Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor. Mediators Inflamm (1997) 1.21
Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol (2001) 1.21
Three phases in homologous pairing: polymerization of recA protein on single-stranded DNA, synapsis, and polar strand exchange. Cold Spring Harb Symp Quant Biol (1983) 1.20
Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol (1999) 1.19
Pathogenesis of thrombosis in patients with malignancy. Int J Hematol (2001) 1.18
Intermediates in homologous pairing promoted by RecA protein and correlations of recombination in vitro and in vivo. Cold Spring Harb Symp Quant Biol (1984) 1.18
Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology (1983) 1.15
Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis (2009) 1.15
Platelet hyperaggregability and the nephrotic syndrome. Thromb Res (1979) 1.12
E. coli recA protein possesses a strand separating activity on short duplex DNAs. EMBO J (1985) 1.12
Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J Leukoc Biol (1989) 1.10
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood (1983) 1.10
Unwinding associated with synapsis of DNA molecules by recA protein. Proc Natl Acad Sci U S A (1983) 1.10
A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J (2003) 1.10
Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immun (1986) 1.09
Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol (2000) 1.09
Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J Biol Chem (1995) 1.08
Evidence that cells from experimental tumours can activate coagulation factor X. Br J Cancer (1979) 1.07
Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J Biol Chem (1994) 1.07
Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. Proc Natl Acad Sci U S A (1995) 1.07
Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost (2001) 1.07
Mutational analysis of the DNA binding domain A of chromosomal protein HMG1. Nucleic Acids Res (1994) 1.06
[Experimental orthopic liver transplant]. Rev Esp Enferm Apar Dig (1972) 1.06
Risk factors for urinary incontinence in women. Eur Urol (2000) 1.05
Familial deficiency of a plasma factor stimulating vascular prostacyclin activity. Thromb Res (1979) 1.05
Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun (1984) 1.05
Malignancy and haemostasis. Br J Haematol (1980) 1.04
IFN-beta-induced reduction of superoxide anion generation by macrophages. Immunology (1982) 1.04
Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport (1999) 1.04
1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandinE(2)production. Pharmacol Res (2001) 1.03
Spontaneous and gamma-aminobutyric acid (GABA)-activated GABA(A) receptor channels formed by epsilon subunit-containing isoforms. Mol Pharmacol (1999) 1.03
Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. Cancer Res (1985) 1.02
Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism. J Immunol (1984) 1.02
The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy (2006) 1.01
Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer (1985) 1.01
A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun (1992) 1.00
Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis. Rev Eur Etud Clin Biol (1970) 1.00
Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br J Pharmacol (2003) 1.00
Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging (2014) 1.00
Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer (1983) 0.99
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Ther (2002) 0.99